Definitive Healthcare announced its financial results for the fourth quarter and full fiscal year ended December 31, 2024. For Q4 2024, revenue was $60.0 million, a 6% decrease year-over-year from $63.8 million in Q4 2023, but exceeded the high end of guidance. Adjusted EBITDA for the quarter was $19.0 million, representing a 32% margin, also above guidance.
For the full year 2024, total revenue reached $250.0 million, a 5% decline from $263.2 million in fiscal year 2023, yet it surpassed the high end of the company's guidance. Full year adjusted EBITDA was $77.0 million, achieving a 31% margin, which also exceeded guidance.
The company announced a key executive transition, with Casey Heller, Senior Vice President of Finance, appointed as the new Chief Financial Officer, effective June 2, 2025. Current CFO Rick Booth will continue in his role until early June to ensure a smooth transition and allow time to backfill Ms. Heller's previous position.
Looking ahead, Definitive Healthcare provided guidance for the first quarter of 2025, projecting revenue between $58.5 million and $60.0 million, and adjusted EBITDA between $14.0 million and $15.5 million. For the full year 2025, revenue is expected to be between $234.0 million and $240.0 million, representing a 5% to 7% decline compared to 2024, with adjusted EBITDA guided between $61.0 million and $65.0 million.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.